Drug intelligence / Profile preview

Puumala virus DNA vaccine

Development stage
Phase 2
Lead developer
U.S. Army Medical Research and Development Command
Modality
DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

The Puumala virus DNA vaccine is an investigational DNA-based vaccine designed to prevent Hemorrhagic Fever with Renal Syndrome (HFRS) or Nephropathia epidemica caused by the Puumala virus (PUUV). It utilizes the pWRG7077 plasmid backbone to deliver the M segment of the Puumala virus genome, which encodes the viral envelope glycoproteins (Gn and Gc). Following intramuscular administration—often facilitated by electroporation or needle-free jet injection—the plasmid enters host cells and expresses these glycoproteins, which then serve as antigens to stimulate a protective immune response, including the production of neutralizing antibodies. This vaccine is frequently evaluated both as a monotherapy and as part of a multivalent formulation with the Hantaan virus DNA vaccine to provide broad protection against major hantaviruses endemic in Eurasia.

Other names
PUUV DNA vaccinePuumala virus plasmid DNA vaccinepWRG/PUU-M
02

Targets

Puumala virus glycoprotein GcPUUV Gn (Puumala virus envelope glycoprotein Gn)

Beyond the preview

Go deeper on Puumala virus DNA vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Puumala virus DNA vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call